Medicare Part D coverage · azelaic acid · RxCUI 1043753
azelaic acid 200 MG/ML Topical Cream [Azelex]
Per the CMS 2026 Part D formulary file, azelaic acid 200 MG/ML Topical Cream [Azelex] is covered by 161 Medicare Part D plans (3.2% of enrollable products), averaging Tier 3.4, with prior authorization required on 0% of covering formularies.
- 3.2%
- Plan coverage
- 161
- Plans covering
- T3.4
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for azelaic acid 200 MG/ML Topical Cream [Azelex]
Per the CMS 2026 Part D formulary file, azelaic acid 200 MG/ML Topical Cream [Azelex] (RxNorm concept RXCUI 1043753, generic name azelaic acid) appears on 23 distinct formulary files spanning 161 Medicare Part D plan offerings - 3.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.4.
Real-world access to azelaic acid 200 MG/ML Topical Cream [Azelex] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 8.7% require step therapy. 4.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 37,203 Part D beneficiaries filled azelaic acid 200 MG/ML Topical Cream [Azelex] in 2023, with total plan-and-beneficiary spending of $9,731,946 and an average per-beneficiary annual cost of $261.59. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry azelaic acid 200 MG/ML Topical Cream [Azelex] today.
Coverage Details
- Formularies covering
- 23
- Plans covering
- 161
- Coverage rate
- 3.2%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 8.7% of formularies
- Quantity limits
- 4.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 37,203
- Total spending
- $9,731,946
- Avg per beneficiary
- $261.59
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering azelaic acid 200 MG/ML Topical Cream [Azelex]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T4 | No | $0 | CO |
| Select Health Medicare Flex (HMO) | Selecthealth, Inc. | T4 | No | $0 | CO |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T4 | No | $0 | CO |
| Select Health Medicare Active (HMO) | Selecthealth, Inc. | T4 | No | $0 | CO |
| Select Health Medicare Dual (HMO D-SNP) | Selecthealth, Inc. | T4 | No | $0 | NV |
| Select Health Medicare Wellness (HMO) | Selecthealth, Inc. | T4 | No | $0 | NV |
| Medicare BlueEssential (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare BlueActive (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare BlueVital (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera SeniorChoice Basic (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera SeniorChoice Extra (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare Blue Choice Core (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T4 | No | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T4 | No | $0 | NY |
| Blue Medicare Essential Plus (HMO-POS) | Blue Cross AND Blue Shield OF North Carolina | T4 | No | $0 | NC |
| Blue Medicare Choice (HMO) | Blue Cross AND Blue Shield OF North Carolina | T4 | No | $0 | NC |
| Blue Medicare Essential (HMO) | Blue Cross AND Blue Shield OF North Carolina | T4 | No | $0 | NC |
| Experience Health Medicare Advantage (HMO) | Blue Cross AND Blue Shield OF North Carolina | T4 | No | $0 | NC |
| Healthy Blue + Medicare (HMO-POS D-SNP) | Blue Cross AND Blue Shield OF North Carolina | T4 | No | $0 | NC |
| Blue Advantage Complete (PPO) | Blue Cross AND Blue Shield OF Alabama | T4 | No | $0 | AL |
| BSW SeniorCare Advantage (PPO) | Baylor Scott & White Insurance Company | T4 | No | $0 | TX |
| BSW SeniorCare Advantage Basic (PPO) | Baylor Scott & White Insurance Company | T4 | No | $0 | TX |
| BSW SeniorCare Advantage (PPO) | Baylor Scott & White Insurance Company | T4 | No | $0 | TX |
| BSW SeniorCare Advantage Select Rx (HMO-POS) | Scott AND White Health Plan | T4 | No | $0 | TX |
| BSW SeniorCare Advantage Premium Rx (HMO-POS) | Scott AND White Health Plan | T4 | No | $0 | TX |
| BSW SeniorCare Advantage Select Rx (HMO-POS) | Scott AND White Health Plan | T4 | No | $0 | TX |
| Blue Cross Medicare Advantage Classic (PPO) | Health Care Service Corporation | T4 | No | $0 | MT |
| Blue Cross Medicare Advantage Choice Plus (PPO) | Hcsc Insurance Services Company | T4 | No | $0 | TX |
| Blue Cross Medicare Advantage Choice Plus (PPO) | Hcsc Insurance Services Company | T4 | No | $0 | TX |
| Blue Cross Medicare Advantage Balance (PPO) | Hcsc Insurance Services Company | T4 | No | $0 | NM |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is azelaic acid 200 MG/ML Topical Cream [Azelex] covered by Medicare Part D?
Yes, azelaic acid 200 MG/ML Topical Cream [Azelex] is covered by 161 Medicare Part D plans (3.2% of all Part D formularies).
What tier is azelaic acid 200 MG/ML Topical Cream [Azelex] on Medicare Part D plans?
azelaic acid 200 MG/ML Topical Cream [Azelex] averages Tier 3.4 across Part D plans, ranging from Tier 1 to Tier 4.
Does azelaic acid 200 MG/ML Topical Cream [Azelex] require prior authorization?
0% of Part D formularies require prior authorization for azelaic acid 200 MG/ML Topical Cream [Azelex]. Step therapy: 8.7%. Quantity limits: 4.3%.
How much does Medicare spend on azelaic acid 200 MG/ML Topical Cream [Azelex]?
In 2023, total Medicare Part D spending on azelaic acid 200 MG/ML Topical Cream [Azelex] was $9,731,946, covering 37,203 beneficiaries. The average spend per beneficiary was $261.59.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] T3.4
- pentosan polysulfate 100 MG Oral Capsule [Elmiron] T3.4
- erythromycin lactobionate 500 MG Injection [Erythrocin] T3.4
- mafenide 85 MG/ML Topical Cream [Sulfamylon] T3.4
- 1 ML darbepoetin alfa 0.06 MG/ML Injection [Aranesp] T3.4
- 1 ML denosumab-dssb 60 MG/ML Prefilled Syringe [Ospomyv] T3.4